Clinical Trials · NCT06821919
Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Western Galilee Hospital-Nahariya
- Enrollment
- 70
- Start date
- May 2024
- Locations
- 1 site, Israel
- Primary endpoint
- NETosis marker- citrullinated histone H3 (citH3)